ddms has been researched along with adamantane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandes, RP; Busse, R; Fleming, I; Hammock, BD; Jung, O; Kim, IH; Schmidt, R; Schweda, F | 1 |
| Berthiaume, M; Corriveau, S; Pasquier, JC; Rousseau, E | 1 |
2 other study(ies) available for ddms and adamantane
| Article | Year |
|---|---|
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Topics: Adamantane; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Lauric Acids; Male; Mice; Mice, Inbred Strains; Natriuresis; Renal Circulation; Solubility; Sulfones; Vasoconstrictor Agents; Vasodilation | 2005 |
Inhibition of epoxy-eicosanoid degradation improves the tocolytic effects of indomethacin in the uterus from pregnant women.
Topics: Adamantane; Adult; Amides; Arachidonic Acid; Cesarean Section; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Eicosanoids; Epoxide Hydrolases; Female; Humans; Indomethacin; Infant, Newborn; Lauric Acids; Myometrium; Pregnancy; Signal Transduction; Sulfones; Tocolytic Agents; Uterine Contraction; Young Adult | 2011 |